Anti-Mullerian hormone (AMH): what do we still need to know?
about
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewFertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessmentThe menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective studyHow do chemotherapeutic agents damage the ovary?AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysisAnti-mullerian hormone as a predictor of time to menopause in late reproductive age womenSerum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic reviewImpact of cancer therapies on ovarian reserveImpact of breast cancer on anti-mullerian hormone levels in young womenPrimate follicular development and oocyte maturation in vitro.Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone.Ovarian Volume in Korean Women with Polycystic Ovary Syndrome and Its Related Factors.Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells.Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metforminAnti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization.Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHHOvarian aging and premature ovarian failure.Reproductive status is associated with the severity of fibrosis in women with hepatitis C.Chronological age vs biological age: an age-related normogram for antral follicle count, FSH and anti-Mullerian hormone.The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels.Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersThe correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile womenAnti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatmentAnti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF.Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols.Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II AssayEffect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signallingSurvival, growth, and maturation of secondary follicles from prepubertal, young, and older adult rhesus monkeys during encapsulated three-dimensional culture: effects of gonadotropins and insulinComparison of two different methods for measuring anti-mullerian hormone in a clinical series.Possible involvement of single nucleotide polymorphisms in anti-Müllerian hormone signaling pathway in the pathogenesis of early OHSS in Han Chinese women.Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.Chemotherapy-Induced Amenorrhea - An UpdateAttenuated AMH signaling pathway plays an important role in the pathogenesis of ovarian hyperstimulation syndrome.Age-related trends in anti-Mullerian hormone serum level in women with unilateral and bilateral ovarian endometriomas prior to surgery.The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LHSerum Anti-Müllerian Hormone Levels before Surgery in Patients with Ovarian Endometriomas Compared to Other Benign Ovarian Cysts.Correlation between three assay systems for anti-Müllerian hormone (AMH) determinationA new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation
P2860
Q26774060-C14788F8-7B90-4191-8D5C-819053C95384Q28077710-86E6BE69-3ADC-41F8-B3D3-38FBE2E783F3Q28248914-9FD25910-CEB2-4079-84D4-933BB42A7102Q28267696-CDF7A76B-BB4A-4D1E-90B4-64A1972EF228Q28289118-2E6F4BD1-0936-4C1C-90DD-EA3E999E9243Q28383911-21A88BEE-F25D-4381-91A0-97CCF7D20B14Q28384104-111E3C0E-472E-4739-919B-840819C67711Q28384958-7682D2DA-49E6-4DE5-857A-DA9E5C8CC8D0Q28392860-12C75C9F-7646-474D-B1DE-B43E93656557Q33557700-0706E69B-F9A9-486B-9ACA-FDC4DF490219Q33646194-AFFC06A7-E121-4588-B67E-5E8EDD2C06F1Q33689353-2F6CE6FE-2689-4B59-8776-D6EF46BB3D3BQ33714979-536C415E-149C-447C-9892-27E9AE072FD1Q34031584-148D8602-858D-48E3-A53C-BBDD4DC92CD6Q34138075-D7BBA42F-ADC2-481D-AC31-497602E1E0DEQ34226336-F9388EFD-786C-4F59-83F3-1749C2B48A56Q34330442-F9110CF7-06D5-4CD2-ADE6-9C1D398E59DFQ34412627-9243F65E-CA09-4AEB-A786-EA52C6ABB7CDQ34954420-51A1DCDA-9418-4A4E-8809-109D20BC949EQ35102795-9FA77D08-AD65-4A01-867A-3D28CD7D2288Q35108269-B144D516-6C9B-485A-B208-73E66D6EE8F9Q35166382-D045097D-1AD6-4730-8CFB-29A108D320E5Q35171104-0A6F9FC9-9569-4407-A167-04D3B8654167Q35181958-72C13260-B183-4DBD-8DAD-6179510C2BEFQ35186943-31D6F783-49EF-48A6-A741-C186AE4BFF83Q35620057-F163AE8E-F1BA-40E0-9C08-EA7B8F27A570Q35822351-343E3EDD-2AB0-4409-9C1F-342A90571E5BQ35926644-E44F2455-A696-4362-B7EB-7B06C4717D62Q35938184-AF176D4D-80B5-4A6B-B57C-613414151951Q35956126-5E8E92A7-900D-49C5-8DBB-0E3B616E4D78Q36086776-E81E5F5E-4CE5-44E3-A440-A3874BE8EC59Q36095415-478A4FF7-6194-4C48-9BCA-0168BAB04D92Q36106435-A2248182-9A88-4212-88C9-1F1DFE1D1841Q36295133-5D8A7C8D-88BD-4AAF-85E4-949E33ED5451Q36309513-54172BAA-ED9D-40B8-A2F7-F1C95DD8093EQ36311015-B01C8B3F-09F1-4474-A73D-C05E70191AD2Q36474823-8F29F502-6CB7-4236-AAE1-157640466F53Q36480470-530D4389-2405-4F36-B411-A3299FC0A710Q36484685-EF876A0D-FAE6-4F0A-A83E-465059C62BBDQ36594368-10CC1F44-94CC-49FE-A614-83BD0C684D59
P2860
Anti-Mullerian hormone (AMH): what do we still need to know?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Anti-Mullerian hormone (AMH): what do we still need to know?
@en
type
label
Anti-Mullerian hormone (AMH): what do we still need to know?
@en
prefLabel
Anti-Mullerian hormone (AMH): what do we still need to know?
@en
P2093
P2860
P356
P1433
P1476
Anti-Mullerian hormone (AMH): what do we still need to know?
@en
P2093
A La Marca
B C Fauser
ESHRE Special Interest Group for Reproductive Endocrinology--AMH Round Table
F J Broekmans
N S Macklon
P2860
P304
P356
10.1093/HUMREP/DEP210
P407
P577
2009-06-11T00:00:00Z